Detalhe da pesquisa
1.
Effects of empagliflozin on proinflammatory cytokines and other coronary risk factors in patients with type 2 diabetes mellitus: A single-arm real-world observation.
Int J Clin Pharmacol Ther
; 59(1): 17-25, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094728